Page 2881 - Cote clinical veterinary advisor dogs and cats 4th
P. 2881
1528 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.
Drain openers toxicosis, 13–15 Ear (Continued) Electrocardiography (ECG)
Draining tracts, 4 cytology of, 1093–1094 abnormalities on, 1220.e1
examination of. See Video otoscopy
ambulatory, 1120–1122, 1121f. See also Holter
actinomycosis/nocardiosis and, 20
VetBooks.ir cutaneous, 275.e2–275.e4, 275.e3f, 1413a Ear flush (deep), 1094.e1–1094.e2 in atrial fibrillation, 94, 95f
monitor
infections of. See Otitis externa; Otitis media
squamous cell carcinoma of, 939–942
fistulogram of, 1114.e2–1114.e3, 1114.e2f
in atrial premature complexes, 97, 97f
foreign bodies and, 275.e2–275.e4, 275.e3f
Dramamine. See Dimenhydrinate
in atrioventricular block, 102, 103f
Ear margin seborrhea, 789
Dramamine II. See Meclizine Ear margin dermatosis, 215–216 in atrial standstill, 101, 101f
Dressings, for shearing/degloving wounds, 910 Ear mites. See Otodectic mange in hyperkalemia, 495–496, 496f
Drisdol. See Ergocalciferol Ear-pedal, 731 in left bundle branch block, 579.e2f
Droncit. See Praziquantel EBP. See Eosinophilic bronchopneumopathy (EBP) procedure for, 1096–1097, 1097f, 1097t
Drontal Plus, for whipworm infection, 1049 Ebstein’s anomaly, 996, 1049.e2 in pulmonary hypertension, 839
Dropped hock. See Achilles tendon injury Eccentrocytes, 1327f, 1335, 1351 in right bundle branch block, 891.e2f, 891.e3
Drowning, 275–276 Ecchymoses, 781–782, 1267.e1, 1439.e3a in sick sinus syndrome, 916, 917f
Drug(s), 1460, 1465–1466, 1471, 1476, 1478, ECG. See Electrocardiography (ECG) in tricuspid valve dysplasia, 996
1481–1482, 1484, 1488, 1490, 1496, 1498–1499, ECGC (green tea), 463t–464t in ventricular arrhythmia, 1035f, 1035.e1f
1503–1504, 1506, 1509, 1510.e1–1510.e5, Echinacea, 463t–464t Electrocution, 292–293, 292f, 292.e2f
1510.e8–1510.e12. See also specific drug Echinoacanthocytes. See Acanthocytes Electrohydraulic lithotripsy, 1127.e3
Drug adverse reactions. See also specific drugs Echinococcosis, 281.e1–281.e2 Electrolyte(s). See specific electrolytes
anemia, 1197 Echinococcus granulosis, 281.e1 Electrolyte supplementation, for refeeding syndrome,
barbiturates and, 110.e3–110.e5 Echinococcus multilocularis, 281.e1 871.e2–871.e4, 871.e3t
chemotherapy and, 152–154, 153.e1f, 818 Echinococcus oligarthrus, 281.e1 Electromyography (EMG), 1097.e1–1097.e3,
erythema multiforme and toxic epidermal necrolysis, Echinococcus vogeli, 281.e1 1097.e1f–1097.e3f
309.e2–309.e3 Echocardiography in caudal myopathy, 149.e2
fetal adverse effects, 818 in atrial septal defect, 99.e2–99.e3 in forelimb paresis, 756
fever of unknown origin, 1223–1225 in hemangiosarcoma, 425 in masticatory myositis, 637
gastrointestinal ulceration, 1225 in patent ductus arteriosus, 765 in tick paralysis, 977
hematemesis, 1228 procedure for, 1094–1096, 1095f–1096f, 1096.e1f Electrophoresis. See Protein electrophoresis
infertility, 1247 in pulmonary hypertension, 839 Electroretinogram (ERG), 1097.e3–1097.e5, 1097.e5f
nephrotoxicity, 1256 in pulmonic stenosis, 844 Elimination behavior problems. See Inappropriate
nonsteroidal antiinflammatory drugs and, 695–697 in restrictive/unclassified cardiomyopathy, 882 elimination
ototoxicity, 237, 1263 in subaortic stenosis, 949 Elimination food trial, for food allergy, 348
in pregnancy, 818 in tricuspid valve dysplasia, 996 Elixophyllin. See Theophylline
Drug allergy, 227 in ventricular septal defect, 1036 Elmiron. See Pentosan polysulfate
Drug eruption, 227 Eclampsia, 281–282 Elspar. See L-Asparaginase
Drug interactions, 1510.e1–1510.e5 Ectasy. See Amphetamine toxicosis Emaciation. See Cachexia; Malnutrition; Weight loss
Dry eye. See Keratoconjunctivitis sicca (KCS) Ectopic cilia, 273–275, 274f Embedded teeth. See Unerupted teeth
DSS. See Dioctyl sodium sulfosuccinate (DSS) Ectopic ureters, 282–284, 1085 Embolism. See also Thromboembolism
DTIC. See Dacarbazine (DTIC) excretory urogram of, 1101f fibrocartilaginous, 336–337
DTM (dermatophyte test medium). See Dermatophyte and urinary incontinence, 539 and hindlimb paresis, 758
culture vaginal abnormalities and, 1027 Embolus, 74
Ductus arteriosus, patent. See Patent ductus arteriosus Ectropion, 296–298 Embryonic vesicles, 817
(PDA) Eculizumab, 431.e3 Emergency drugs, 1079t
Dulcolax. See Bisacodyl Eczema, moist. See Acute moist dermatitis Emesis induction, 1188–1189. See also Vomiting
Duodenotomy Edema. See also Angioedema Emetics. See also specific drugs
for bile duct obstruction, 118 causes of, 1219 for alcohol intoxication, 44.e2
for chole(cysto)lithiasis, 163 corneal, 205.e2–205.e3 for amphetamine toxicosis, 50
Duragesic. See Fentanyl lymphedema, 602.e2–602.e3 contraindications for, 1188–1189
Duricef. See Cefadroxil pulmonary. See Pulmonary edema indications for, 1188–1189
Dursban, 718 subcutaneous, 284–285, 284f for muscle relaxant toxicosis, 109
Dutch kooiker Edetate. See Calcium EDTA uses of, 1188–1189
familial nephropathy in, 169 Edrophonium EMG. See Electromyography (EMG)
renal dysplasia in, 875 administration and dosage of, 1476 Emodepside, 639, 1510.e6t
von Willebrand disease in, 1043 in myasthenia gravis test, 669 Emotional abuse, 9
Dwarf weimaraner, 531 EDTA. See Calcium EDTA Emphysema
Dwarfism. See Pituitary dwarfism Effusions bullous. See Pulmonary bullae
Dysautonomia, 276.e2–276.e3, 642 analysis of, 1343–1344 subcutaneous, 950.e2–950.e3, 950.e3f
megacolon and, 202 bicavitary, 1220 Emphysematous cholecystitis, 165.e2, 455
Dyscoria, 213, 846 characteristics of, 1220 Emphysematous cystitis, 234
Dysfibrinogen syndrome. See Disseminated intravascular mesothelioma and, 651 Enacard. See Enalapril maleate
coagulation (DIC) pericardial. See Pericardial effusion Enalapril maleate
Dysgerminoma, 733–734, 734.e2f peritoneal. See Ascites administration and dosage of, 1476
Dysmyelination, 994 pleural. See Pleural effusion for chronic heart failure, 411
Dysphagia, 277–278 Effusive-constrictive pericarditis, 186 for hypertension, 502
causes of, 1218 Efudex. See 5-Fluorouracil (5-FU) for myxomatous valve disease, 99
cricopharyngeal achalasia and, 222–223 EG poisoning. See Ethylene glycol intoxication for nephrotic syndrome, 691
pharyngeal, 277 Ehmer sling, 1162, 1162f for proteinuria of glomerulonephritis, 391
Dyspnea Ehrlichia canis, 285–288, 304, 1172.e2t–1172.e4t for restrictive cardiomyopathy, 882
causes of, 1219 Ehrlichia chaffeensis, 287, 1172.e2t–1172.e3t for systemic lupus erythematosus, 956
characteristics of, 879–881 Ehrlichia ewingii, 393–395, 395.e1f, 1172.e2t–1172.e3t for tricuspid valve dysplasia, 997
definition of, 879 Ehrlichia platys. See Anaplasma spp., A. platys Encephalitis. See also Meningoencephalitis
hospital-acquired, 1414a Ehrlichiosis, 393–395, 395.e1f old-dog, 271
with neck flexion, 986 monocytic, 285–288 and vestibular disease, 1038
Dystocia, 278–281, 279f–280f, 1184.e2, 1219.e1 serologic testing for, 1335–1336 Encephalomyelopathy, fibrocartilaginous embolic. See
causes of, 1219 Eisenmenger physiology, 1036 Fibrocartilaginous embolism
management of, 1415a Eisenmenger’s syndrome, 288.e2–288.e3 Encephalopathy
periparturient phenomena versus, 1219.e1 Elapidae, 921, 1450.e1a hepatic, 440–442
Dystrophic calcification, 140.e5 Elavil. See Amitriptyline hyperammonemic, 183
Dystrophic epidermolysis bullosa, 350 Elbow dysplasia, 288–289, 288f, 288.e4f portosystemic shunt and, 814
Dystrophin-deficient muscular dystrophy, 676.e2 Elbow hygroma, 290 retention enema for, 1099
Dysuria. See Stranguria; Urinary incontinence Elbow incongruity, 288 spongiform, 937.e2–937.e3
Elbow joint incongruity. See Elbow dysplasia treatment of, 175
E Elbow luxation, 291–292, 1158–1159 vascular, 293–294
Ear. See also Pinna Eldepryl. See Selegiline End-stage hypertrophic cardiomyopathy, 881
adhesives or glues in, 33 Electrical cardioversion, for atrial fibrillation, 95 Endocardiosis, 294, 658. See also Myxomatous valve
bacterial isolates from, 1202.e1 Electrical defibrillation, 1088–1089, 1089.e1f disease
www.ExpertConsult.com